Nebula Research & Development LLC Has $217,000 Stock Holdings in Mettler-Toledo International Inc. (NYSE:MTD)

Nebula Research & Development LLC decreased its stake in Mettler-Toledo International Inc. (NYSE:MTD - Free Report) by 80.7% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 177 shares of the medical instruments supplier's stock after selling 742 shares during the period. Nebula Research & Development LLC's holdings in Mettler-Toledo International were worth $217,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the stock. Voya Investment Management LLC grew its position in Mettler-Toledo International by 600.4% in the 4th quarter. Voya Investment Management LLC now owns 46,413 shares of the medical instruments supplier's stock worth $56,794,000 after purchasing an additional 39,786 shares during the last quarter. Banco Bilbao Vizcaya Argentaria S.A. grew its holdings in Mettler-Toledo International by 4.6% in the 4th quarter. Banco Bilbao Vizcaya Argentaria S.A. now owns 9,169 shares of the medical instruments supplier's stock worth $11,225,000 after buying an additional 402 shares in the last quarter. Burling Wealth Partners LLC bought a new position in Mettler-Toledo International in the 4th quarter worth approximately $465,000. Mar Vista Investment Partners LLC raised its stake in Mettler-Toledo International by 1.5% during the 4th quarter. Mar Vista Investment Partners LLC now owns 35,037 shares of the medical instruments supplier's stock valued at $42,874,000 after acquiring an additional 530 shares in the last quarter. Finally, Fuller & Thaler Asset Management Inc. boosted its position in Mettler-Toledo International by 31.8% during the 4th quarter. Fuller & Thaler Asset Management Inc. now owns 792 shares of the medical instruments supplier's stock worth $969,000 after acquiring an additional 191 shares during the period. Institutional investors and hedge funds own 95.07% of the company's stock.

Insider Transactions at Mettler-Toledo International

In other Mettler-Toledo International news, insider Gerry Keller sold 600 shares of the stock in a transaction on Monday, February 10th. The shares were sold at an average price of $1,351.34, for a total transaction of $810,804.00. Following the transaction, the insider now directly owns 6 shares of the company's stock, valued at $8,108.04. This represents a 99.01 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Christian Magloth sold 790 shares of the company's stock in a transaction dated Monday, February 24th. The stock was sold at an average price of $1,313.69, for a total value of $1,037,815.10. Following the sale, the insider now owns 734 shares of the company's stock, valued at approximately $964,248.46. This trade represents a 51.84 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 1.94% of the company's stock.

Mettler-Toledo International Price Performance

MTD traded down $2.83 on Wednesday, reaching $1,060.54. 57,951 shares of the company traded hands, compared to its average volume of 145,900. Mettler-Toledo International Inc. has a 52-week low of $946.69 and a 52-week high of $1,546.93. The company has a market cap of $22.10 billion, a price-to-earnings ratio of 26.16, a PEG ratio of 3.30 and a beta of 1.40. The stock's 50 day moving average price is $1,129.03 and its 200-day moving average price is $1,228.33.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last posted its quarterly earnings results on Thursday, May 1st. The medical instruments supplier reported $8.19 EPS for the quarter, beating the consensus estimate of $7.90 by $0.29. Mettler-Toledo International had a net margin of 22.29% and a negative return on equity of 591.54%. The business had revenue of $883.74 million for the quarter, compared to analysts' expectations of $876.61 million. During the same period in the previous year, the company posted $8.89 EPS. Mettler-Toledo International's revenue was down 4.6% on a year-over-year basis. As a group, equities research analysts forecast that Mettler-Toledo International Inc. will post 42.71 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several brokerages recently commented on MTD. Robert W. Baird dropped their target price on Mettler-Toledo International from $1,369.00 to $1,034.00 and set a "neutral" rating on the stock in a report on Tuesday, April 22nd. StockNews.com downgraded Mettler-Toledo International from a "buy" rating to a "hold" rating in a research note on Monday. Citigroup raised Mettler-Toledo International from a "neutral" rating to a "buy" rating and set a $1,400.00 target price on the stock in a report on Monday, April 7th. Jefferies Financial Group upgraded shares of Mettler-Toledo International from an "underperform" rating to a "hold" rating and cut their price target for the company from $1,200.00 to $1,110.00 in a report on Monday. Finally, Wells Fargo & Company lifted their price objective on shares of Mettler-Toledo International from $1,125.00 to $1,200.00 and gave the stock an "equal weight" rating in a research report on Monday. Seven research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of "Hold" and a consensus target price of $1,296.13.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.